Illumina (ILMN) Financial Analysis & Valuation | Quarter Chart

Illumina (ILMN)

ILMN
Price: $135.78
Fair Value: 🔒
🔒score
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive he... more
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its p... more
Description Shares
Market Cap$20.63BExchangeNASDAQ
SectorHealthcareIndustryMedical - Diagnostics & Research
CountryUSCEOJacob Thaysen
IPO Date2000-07-28CAGR0.42%
Employees8,970Websitewww.illumina.com
Div. YieldPayout Ratio
Buy Back Yield2.63%Total Yield2.63%
ILMN chart loading...
Fundamentals Technicals
Enterprise Value$19.86BP/E Ratio21.24
Forward P/E23.07PEG Ratio4.05
P/S Ratio4.7P/B Ratio6.86
P/CF Ratio18.42P/FCF Ratio20.86
EPS$5.44EPS Growth 1Y-190.33%
EPS Growth 3Y-119.28%EPS Growth 5Y28.79%
Revenue Growth 1Y1.25%Gross Margin0.67%
Operating Margin0.21%Profit Margin0.19%
ROE0.33%ROA0.13%
ROCE0.18%Current Ratio1.75
Quick Ratio1.36Cash Ratio0.7
Debt/Equity0.81Interest Coverage12.09
Altman Z Score4.82Piotroski Score6